GLA announces its 2019 research grant recipients. The funded initiatives range from diagnosing pediatric Lyme disease, new treatment protocols, to evaluating Lyme and suicide risks
More Than 2 Million by 2020: New Study by Scientists at Global Lyme Alliance and Brown University Estimates the Number of Post-Treatment Lyme Disease Cases in the U.S.
The State of Lyme Disease. Outbreak News interviewed GLA’s Chief Scientific Officer Timothy Sellati, Ph.D. for its latest podcast. Topics include Lyme disease, the Tick-borne Disease Working Group’s Report, and the IDSA
Thank you to everyone who helped us make GLA’s 4th Annual NYC Gala a tremendous success! Check out speeches, videos, photos, and more
NYC Gala 2018 – One Month Away! Join Team GLA at the biggest and most important fundraising event of the year. Seating is limited!
GLA exceeds $10 million in Lyme disease research funding
Support GLAs mission this Lyme Disease Awareness Month. Receive a limited-edition Ally Hilfiger gift with your donation.
First Multiplex Test for Tick-Borne Disease A look at the new Tick-Borne Disease Serochip diagnostic blood test.
WIN 2 TICKETS 2 NYC GALA!
Your donation could win you 2 tickets to GLA’s NYC Gala on October 11, 2017. The evening will honor Joseph Abboud and Marisol Thomas, with special live performance by Rob Thomas and Chris Daughtry!
WHAT’S NEW. GLA’s Greenwich Gala, hosted by journalist Gretchen Carlson, honored singer-songwriter Marina Morgan and research trailblazer Dr. Harriet Kotsoris. Funds raised at the sold-out event go toward Lyme disease research, education and awareness initiatives.
WHAT’S NEW. GLA is awarding nearly $2 million in 2016-17 grants. The grantees are top researchers working on a wide array of projects to better understand the disease and improve its diagnosis, treatment and prevention.
WHAT’S NEW. GLA’s “Uniting for a Lyme-Free World” Gala was a tremendous success. Funds raised at the New York City event will go toward our current research grants cycle as well as education and awareness initiatives.